Paper3941019
Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes.
Rubas W and 6 others. Int J Cancer, 1986. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes. Papers, record 3941019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3941019
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytarabine | Major topic |
| Leukemia L1210 | Major topic |
| Liposomes | Major topic |
| Melanoma | Major topic |
| Animals | |
| Bone Marrow | |
| Female | |
| Mice | |
| Mice, Inbred C57BL | |
| Mice, Inbred DBA |
Source PubMed
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31015736 | A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability. | Acta Pharmacol Sin | 2019 | https://conductscience.org/library/papers/31015736 | PubMed |
| 25469211 | Clinical potential of elacytarabine in patients with acute myeloid leukemia. | Ther Adv Hematol | 2014 | https://conductscience.org/library/papers/25469211 | PubMed |
| 20049941 | Delivery of therapeutic proteins. | J Pharm Sci | 2010 | https://conductscience.org/library/papers/20049941 | PubMed |
| 18385837 | Nucleoside, nucleotide and oligonucleotide based amphiphiles: a successful marriage of nucleic acids with lipids. | Org Biomol Chem | 2008 | https://conductscience.org/library/papers/18385837 | PubMed |
| 17614355 | Targeted pharmaceutical nanocarriers for cancer therapy and imaging. | AAPS J | 2007 | https://conductscience.org/library/papers/17614355 | PubMed |
| 12162758 | Clinical pharmacokinetics of cytarabine formulations. | Clin Pharmacokinet | 2002 | https://conductscience.org/library/papers/12162758 | PubMed |
| 10408395 | Low density lipoprotein and liposome mediated uptake and cytotoxic effect of N4-octadecyl-1-beta-D-arabinofuranosylcytosine in Daudi lymphoma cells. | Br J Cancer | 1999 | https://conductscience.org/library/papers/10408395 | PubMed |
| 9083333 | Comparative pharmacokinetic and cytotoxic analysis of three different formulations of mitoxantrone in mice. | Br J Cancer | 1997 | https://conductscience.org/library/papers/9083333 | PubMed |
| 8954169 | Lipophilic 1-beta-D-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model. | J Cancer Res Clin Oncol | 1996 | https://conductscience.org/library/papers/8954169 | PubMed |
| 8576276 | Oral antitumour activity in murine L1210 leukaemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1-beta-D-arabinofuranosylcytosine. | J Cancer Res Clin Oncol | 1996 | https://conductscience.org/library/papers/8576276 | PubMed |
| 7734320 | Cellular pharmacology of a liposomal preparation of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine, a lipophilic derivative of 1-beta-D-arabinofuranosylcytosine. | Br J Cancer | 1995 | https://conductscience.org/library/papers/7734320 | PubMed |
| 7554040 | Cellular pharmacology of N4-hexadecyl-1-beta-D-arabinofuranosylcytosine in the human leukemic cell lines K-562 and U-937. | Cancer Chemother Pharmacol | 1995 | https://conductscience.org/library/papers/7554040 | PubMed |
| 3208792 | Incorporation of chlorpromazine into bilayer liposomes for protection against microsomal metabolism and liver absorption. | Eur J Drug Metab Pharmacokinet | 1988 | https://conductscience.org/library/papers/3208792 | PubMed |
| 2013113 | Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes and analysis of their pharmacokinetic properties, acute toxicity, and antitumor efficacy. | Cancer Chemother Pharmacol | 1991 | https://conductscience.org/library/papers/2013113 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3941019
GET https://conductscience.org/api/papers/v1/3941019/authors